Troy Wilson Q&A
We would like to invite you to a talk and Q&A session by serial biotech entrepreneur Troy Wilson. Dr. Wilson was most recently founder and CEO of Intellikine, an oncology drug development company that was recently acquired by Takeda Pharmaceuticals for $310 million. He will present a case study on how to prepare a successful business plan for a fledgling venture, and how to convince investors to buy in to your idea. Join us on Wednesday 1/25 at 2 pm in 101 Schlinger for what is sure to be an excellent talk by a highly successful entrepreneur.
Troy Wilson was most recently President, CEO, and a co-founder of Intellikine, acquired by Takeda Pharmaceuticals in January 2012. Dr. Wilson was formerly co-founder and Chief Business Officer at Ambrx, a biotechnology company focused on the optimization of protein-based medicines using non-natural amino acids as well as a co-founder of Wildcat Discovery Technologies. He previously served as Vice President, Business Development and General Counsel at the Genomics Institute of the Novartis Research Foundation (GNF) in San Diego where he played a key role in the creation and launch of several spinout companies. Dr. Wilson received his Ph.D. in bioorganic chemistry from the University of California, Berkeley and his law degree from New York University.
We hope to see you there!